NO20082112L - 3-Amino-2-arylpropylazaindoler og deres anvendelse - Google Patents
3-Amino-2-arylpropylazaindoler og deres anvendelseInfo
- Publication number
- NO20082112L NO20082112L NO20082112A NO20082112A NO20082112L NO 20082112 L NO20082112 L NO 20082112L NO 20082112 A NO20082112 A NO 20082112A NO 20082112 A NO20082112 A NO 20082112A NO 20082112 L NO20082112 L NO 20082112L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- arylpropylazaindoles
- amino
- methods
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74127205P | 2005-11-30 | 2005-11-30 | |
PCT/EP2006/068650 WO2007062998A1 (en) | 2005-11-30 | 2006-11-20 | 3-amino-2-arylpropyl azaindoles and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082112L true NO20082112L (no) | 2008-06-23 |
Family
ID=37667384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082112A NO20082112L (no) | 2005-11-30 | 2008-05-06 | 3-Amino-2-arylpropylazaindoler og deres anvendelse |
Country Status (17)
Country | Link |
---|---|
US (2) | US7638517B2 (pt) |
EP (1) | EP1957488B1 (pt) |
JP (1) | JP2009517432A (pt) |
KR (1) | KR101026570B1 (pt) |
CN (1) | CN101321752A (pt) |
AR (1) | AR057188A1 (pt) |
AT (1) | ATE442368T1 (pt) |
AU (1) | AU2006319233B9 (pt) |
BR (1) | BRPI0619184A2 (pt) |
CA (1) | CA2632284A1 (pt) |
DE (1) | DE602006009138D1 (pt) |
ES (1) | ES2329413T3 (pt) |
NO (1) | NO20082112L (pt) |
RU (1) | RU2008120141A (pt) |
TW (1) | TW200804376A (pt) |
WO (1) | WO2007062998A1 (pt) |
ZA (1) | ZA200804299B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2912744B1 (fr) * | 2007-02-16 | 2012-09-07 | Centre Nat Rech Scient | Composes pyrrolo°2,3-b!pyridine,composes azaindoles utiles dans la synthese de ces composes pyrrolo°2,3-b!pyridine, leurs procedes de fabrication et leurs utilisations. |
US7871802B2 (en) * | 2007-10-31 | 2011-01-18 | E.I. Du Pont De Nemours And Company | Process for enzymatically converting glycolonitrile to glycolic acid |
US8101642B2 (en) | 2008-06-05 | 2012-01-24 | Sk Biopharmaceuticals Co., Ltd. | 3-substituted propanamine compounds |
CN102026988B (zh) * | 2008-06-05 | 2013-07-03 | 爱思开生物制药株式会社 | 3-取代的丙胺化合物 |
JP2012509342A (ja) | 2008-11-20 | 2012-04-19 | オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド | 置換ピロロ[2,3−b]−ピリジンおよび−ピラジン |
US8222416B2 (en) | 2009-12-14 | 2012-07-17 | Hoffmann-La Roche Inc. | Azaindole glucokinase activators |
AR081039A1 (es) | 2010-05-14 | 2012-05-30 | Osi Pharmaceuticals Llc | Inhibidores biciclicos fusionados de quinasa |
US20130072495A1 (en) * | 2010-05-14 | 2013-03-21 | OSI Pharmaceuticals, LLC | Fused bicyclic kinase inhibitors |
US20140088114A1 (en) | 2011-05-16 | 2014-03-27 | OSI Pharmaceuticals ,LLC | Fused bicyclic kinase inhibitors |
AR098436A1 (es) * | 2013-11-19 | 2016-05-26 | Actelion Pharmaceuticals Ltd | Compuestos tricíclicos de piperidina |
CN108034283B (zh) * | 2017-12-15 | 2020-10-13 | 淮海工学院 | 一种聚乙二醇化苯并吲哚七甲川菁染料及其制备方法和应用 |
US20220098210A1 (en) * | 2019-01-29 | 2022-03-31 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Quindoline compounds and uses thereof |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB705652A (en) | 1948-10-01 | 1954-03-17 | Farbewerke Hoechst Ag | Manufacture of 3-aminopropane compounds |
DE849108C (de) | 1948-10-01 | 1952-09-11 | Hoechst Ag | Verfahren zur Herstellung von 1-disubstituierten 3-Aminopropanen |
NL82464C (pt) * | 1952-01-05 | |||
US2708197A (en) * | 1952-05-24 | 1955-05-10 | Upjohn Co | Preparation of (hydroxy-3-indole)-alkylamines |
US2984670A (en) * | 1959-05-22 | 1961-05-16 | Upjohn Co | Novel 3-(1-hydroxy-1-phenyl-3-aminopropyl) indoles |
GB992731A (en) | 1962-09-28 | 1965-05-19 | Koninklijke Pharma Fab Nv | Aminoalkyl-indolyl-benzyl alcohols |
US4616080A (en) | 1984-07-02 | 1986-10-07 | Eli Lilly And Company | Simplified process of forming crystalline ceftazidime pentahydrate |
KR880007433A (ko) * | 1986-12-22 | 1988-08-27 | 메리 앤 터커 | 3-아릴옥시-3-치환된 프로판아민 |
US4956388A (en) * | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
EP0424525B1 (en) * | 1987-12-11 | 1994-12-21 | Mitsui Petrochemical Industries, Ltd. | Novel amines and their use |
JPH0314562A (ja) | 1988-04-11 | 1991-01-23 | Nippon Chemiphar Co Ltd | 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤 |
US4902710A (en) * | 1988-12-14 | 1990-02-20 | Eli Lilly And Company | Serotonin and norepinephrine uptake inhibitors |
FR2674522B1 (fr) | 1991-03-26 | 1993-07-16 | Lipha | Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant. |
US5177088A (en) | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
US5185350A (en) | 1991-09-23 | 1993-02-09 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles |
EP0600830A1 (de) | 1992-11-27 | 1994-06-08 | Ciba-Geigy Ag | Substituierte Derivate von Diaminophthalimid als Protein-Tyrosin-Kinase-Hemmer |
GB9225141D0 (en) | 1992-12-01 | 1993-01-20 | Smithkline Beecham Corp | Chemical compounds |
GB9518552D0 (en) | 1995-09-11 | 1995-11-08 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
GB9523948D0 (en) | 1995-11-23 | 1996-01-24 | Univ East Anglia | Process for preparing n-benzyl indoles |
JPH09176162A (ja) | 1995-12-22 | 1997-07-08 | Toubishi Yakuhin Kogyo Kk | チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物 |
US6686353B1 (en) | 1996-05-20 | 2004-02-03 | Teijin Intellectual Property Center Limited | Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
JP2002511835A (ja) | 1996-06-07 | 2002-04-16 | エヌピーエス・ファーマシウティカルズ・インコーポレイテッド | 神経障害および神経病の治療に有用な受容体作動性カルシウムチャネル上の新規部位で活性な化合物 |
SE9701144D0 (sv) | 1997-03-27 | 1997-03-27 | Pharmacia & Upjohn Ab | Novel compounds, their use and preparation |
EP0887348A1 (en) | 1997-06-25 | 1998-12-30 | Boehringer Mannheim Italia S.p.A. | Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |
CA2303830A1 (en) | 1997-09-26 | 1999-04-08 | Merck & Co., Inc. | Novel angiogenesis inhibitors |
AU1124399A (en) | 1997-10-28 | 1999-05-17 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
CA2308069A1 (en) | 1997-10-28 | 1999-05-06 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
FR2780890B3 (fr) | 1998-07-10 | 2000-09-01 | Sanofi Sa | Utilisation d'une composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et l'indomethacine pour le traitement des glomerulonephrites chroniques |
DE69935331T2 (de) | 1998-07-13 | 2007-10-31 | NPS Pharmaceuticals, Inc., Salt Lake City | Verfahren und verbindungen zur behandlung der depression |
SE9903998D0 (sv) | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
FR2814073B1 (fr) | 2000-09-21 | 2005-06-24 | Yang Ji Chemical Company Ltd | Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition |
CN1235583C (zh) | 2001-03-05 | 2006-01-11 | 特兰斯泰克制药公司 | 用作治疗剂的苯并咪唑衍生物 |
GB0112122D0 (en) * | 2001-05-18 | 2001-07-11 | Lilly Co Eli | Heteroaryloxy 3-substituted propanamines |
CA2464333C (en) | 2001-10-26 | 2011-07-26 | University Of Connecticut | Heteroindanes: a new class of potent cannabimimetic ligands |
AU2002347022A1 (en) | 2001-12-20 | 2003-07-09 | Novo Nordisk A/S | Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten |
AU2002360819A1 (en) | 2001-12-28 | 2003-07-24 | Bayer Corporation | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
US7244847B2 (en) | 2002-02-06 | 2007-07-17 | Isis Pharmaceuticals, Inc. | Benzimidazole compounds |
CA2478183C (en) * | 2002-03-12 | 2010-02-16 | Merck & Co. Inc. | Substituted amides |
EP1494997A4 (en) * | 2002-04-05 | 2007-04-11 | Merck & Co Inc | SUBSTITUTED ARYLAMID |
JP4459629B2 (ja) * | 2002-04-12 | 2010-04-28 | メルク エンド カムパニー インコーポレーテッド | 二環式アミド |
ATE406363T1 (de) | 2003-05-09 | 2008-09-15 | Hoffmann La Roche | Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten |
WO2005005439A1 (en) | 2003-07-09 | 2005-01-20 | Suven Life Sciences Limited | Benzothiazino indoles |
EP1663113A4 (en) * | 2003-09-18 | 2007-06-13 | Merck & Co Inc | SUBSTITUTED SULFONAMIDES |
EP1682494A4 (en) * | 2003-10-30 | 2006-11-08 | Merck & Co Inc | ARALKYLAMINES AS MODULATORS OF CANNABINOID RECEPTORS |
US7517899B2 (en) * | 2004-03-30 | 2009-04-14 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
CN1993321A (zh) * | 2004-06-01 | 2007-07-04 | 弗·哈夫曼-拉罗切有限公司 | 作为单胺再摄取抑制剂的3-氨基-1-芳基丙基吲哚类化合物 |
BRPI0616459A2 (pt) * | 2005-09-29 | 2011-06-21 | Wyeth Corp | compostos das fórmulas i, ii, e iii; processos para o tratamento ou para a prevenção de: um estado de saúde com melhora devido à recaptação de monoamina; pelo menos um sintoma vasomotor; pelo menos um distúrbio depressivo; pelo menos uma disfunção sexual; para a prevenção de dor; de distúrbio gastrointestinal ou genitourinário; de sìndrome de fadiga crÈnica; de sìndrome de fibromialgia; de esquizofrenia; e uso de um composto |
-
2006
- 2006-11-20 ES ES06819602T patent/ES2329413T3/es active Active
- 2006-11-20 CN CNA2006800451404A patent/CN101321752A/zh active Pending
- 2006-11-20 EP EP06819602A patent/EP1957488B1/en not_active Not-in-force
- 2006-11-20 WO PCT/EP2006/068650 patent/WO2007062998A1/en active Application Filing
- 2006-11-20 JP JP2008542715A patent/JP2009517432A/ja active Pending
- 2006-11-20 KR KR1020087012919A patent/KR101026570B1/ko not_active IP Right Cessation
- 2006-11-20 AT AT06819602T patent/ATE442368T1/de active
- 2006-11-20 BR BRPI0619184-3A patent/BRPI0619184A2/pt not_active IP Right Cessation
- 2006-11-20 CA CA002632284A patent/CA2632284A1/en not_active Abandoned
- 2006-11-20 RU RU2008120141/04A patent/RU2008120141A/ru not_active Application Discontinuation
- 2006-11-20 AU AU2006319233A patent/AU2006319233B9/en not_active Ceased
- 2006-11-20 DE DE602006009138T patent/DE602006009138D1/de active Active
- 2006-11-28 TW TW095143987A patent/TW200804376A/zh unknown
- 2006-11-28 AR ARP060105231A patent/AR057188A1/es unknown
- 2006-11-29 US US11/605,729 patent/US7638517B2/en not_active Expired - Fee Related
-
2008
- 2008-05-06 NO NO20082112A patent/NO20082112L/no not_active Application Discontinuation
- 2008-05-19 ZA ZA200804299A patent/ZA200804299B/xx unknown
-
2009
- 2009-11-16 US US12/619,275 patent/US20100056499A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR101026570B1 (ko) | 2011-03-31 |
KR20080064192A (ko) | 2008-07-08 |
US7638517B2 (en) | 2009-12-29 |
AU2006319233B9 (en) | 2011-09-29 |
JP2009517432A (ja) | 2009-04-30 |
ATE442368T1 (de) | 2009-09-15 |
BRPI0619184A2 (pt) | 2011-09-13 |
CA2632284A1 (en) | 2007-06-07 |
EP1957488A1 (en) | 2008-08-20 |
US20100056499A1 (en) | 2010-03-04 |
ZA200804299B (en) | 2009-04-29 |
TW200804376A (en) | 2008-01-16 |
AR057188A1 (es) | 2007-11-21 |
ES2329413T3 (es) | 2009-11-25 |
WO2007062998A1 (en) | 2007-06-07 |
DE602006009138D1 (de) | 2009-10-22 |
AU2006319233A1 (en) | 2007-06-07 |
CN101321752A (zh) | 2008-12-10 |
RU2008120141A (ru) | 2010-01-10 |
US20070123535A1 (en) | 2007-05-31 |
AU2006319233B2 (en) | 2011-06-02 |
EP1957488B1 (en) | 2009-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082112L (no) | 3-Amino-2-arylpropylazaindoler og deres anvendelse | |
NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
NO20081844L (no) | Terapeutiske forbindelser | |
DK2324008T3 (da) | Diarylpyrazol som protein kinase inhibitorer | |
NO20055496D0 (no) | Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer | |
NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
NO20076134L (no) | Benzamidderivater og anvendelser derav | |
NO20063620L (no) | Arylanilinderivater som beta2 adrenergiske receptoragonister | |
NO20064282L (no) | Morfolinforbindelser | |
NO20092033L (no) | Nye forbindelser | |
SG170101A1 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
NO20065880L (no) | 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor | |
TW200833693A (en) | Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors | |
ATE512961T1 (de) | Amorphes nebivolol hydrochlorid und seine herstellung | |
NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
NO20074703L (no) | Antibakterielle piperidinderivater | |
NO20064010L (no) | Indazolderivater og farmasoytiske preparater inneholdelse slike | |
DK2054418T3 (da) | Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer | |
TW200639156A (en) | New compounds | |
NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
NO20076695L (no) | Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser | |
NO20062453L (no) | Tiozolidinoner, fremstilling og anvendelse derav som legemidler | |
SE0401342D0 (sv) | Therapeutic compounds | |
MY169274A (en) | Fused, tricyclic sulfonamide inhibitors of gamma secretase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |